Jessica Niamh Harding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jessica Niamh Harding has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Paul Charles Fletcher
Univ Cambridge, Dept Psychiat, Cambridge CB2 0SZ, England
2 shared publications- Thomas Santarius
Cambridge University Hospitals NHS Trust
2 shared publications Alexis Joannides
Department of Neurosurgery, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK
1 shared publication- Ali Ansanipour
Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
1 shared publication Amber Steele
Research Strategy & Partnership Hub, Cambridge NIHR Biomedical Research Centre, Cambridge, UK
1 shared publication- Amber Steele
Research Strategy and Partnership Hub, Cambridge University Hospitals Trust, Cambridge, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 23 September 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103514
Surgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study
- 23 September 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103514
Open AccessSurgery for pineal cysts with symptoms in the absence of hydrocephalus: a prospective cohort study
- Open Access
- 28 December 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-11
International web-based survey of patients with non-hydrocephalic symptomatic pineal cysts
Objectives: To report the results of an international patient-reported survey that adds to the growing body of evidence surrounding the role of surgery in the management of a subset of patients with non-hydrocephalic symptomatic pineal cyst. Design: An international web-based survey of health outcomes in patients with nhSPC. Subjects: All survey participants who self-reported a diagnosis of symptomatic pineal cyst without hydrocephalus after radiological imaging. Methods: The survey was developed in collaboration with the patient group Pineal Cyst UK. It was publicised and distributed via several online platforms and social media. Data collected included demographics, cyst size, symptom frequency and severity, number of appointments with healthcare professionals, treatment options trialled, and whether patients underwent surgery. Results: 543 participants (mean age 38.6 years, range 1–83) were included in the analysis, of which 82 (mean age 38.9 years, range 16–72) had undergone cyst resection. After a median period of 18.3 months between date of surgery and date of questionnaire completion, 72 (90%) of the surgical cohort reported overall improvement, and all symptoms improved overall, whereas no symptoms improved overall in the non-surgical cohort. Of the non-surgical cohort (n = 461), 269 participants received some form of conservative treatment, of whom 194 (72.1%) did not experience symptom improvement on any treatment offered. Conclusions: A cohort of patients with nhSPC who participated in this international survey reports substantial and durable improvement in symptom severity and quality of life after pineal cyst resection.
- 28 December 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-11
Open AccessInternational web-based survey of patients with non-hydrocephalic symptomatic pineal cysts
Objectives: To report the results of an international patient-reported survey that adds to the growing body of evidence surrounding the role of surgery in the management of a subset of patients with non-hydrocephalic symptomatic pineal cyst. Design: An international web-based survey of health outcomes in patients with nhSPC. Subjects: All survey participants who self-reported a diagnosis of symptomatic pineal cyst without hydrocephalus after radiological imaging. Methods: The survey was developed in collaboration with the patient group Pineal Cyst UK. It was publicised and distributed via several online platforms and social media. Data collected included demographics, cyst size, symptom frequency and severity, number of appointments with healthcare professionals, treatment options trialled, and whether patients underwent surgery. Results: 543 participants (mean age 38.6 years, range 1–83) were included in the analysis, of which 82 (mean age 38.9 years, range 16–72) had undergone cyst resection. After a median period of 18.3 months between date of surgery and date of questionnaire completion, 72 (90%) of the surgical cohort reported overall improvement, and all symptoms improved overall, whereas no symptoms improved overall in the non-surgical cohort. Of the non-surgical cohort (n = 461), 269 participants received some form of conservative treatment, of whom 194 (72.1%) did not experience symptom improvement on any treatment offered. Conclusions: A cohort of patients with nhSPC who participated in this international survey reports substantial and durable improvement in symptom severity and quality of life after pineal cyst resection.
- Open Access
- 15 October 2024
- Published by Elsevier in Annales Médico-psychologiques, revue psychiatrique
- Vol. 182 (9) , 893-898
Cognitive and Computational Accounts of Delusions: Problems and Progress
- 15 October 2024
- Published by Elsevier in Annales Médico-psychologiques, revue psychiatrique
- Vol. 182 (9) , 893-898
Open AccessCognitive and Computational Accounts of Delusions: Problems and Progress
- 15 March 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (3) , e259192
Sensory neuropathy as a manifestation of multiple acyl-coenzyme A dehydrogenase deficiency
Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is a rare metabolic disorder which typically manifests with muscle weakness. However, despite late-onset MADD being treatable, it is often misdiagnosed, due in part to the heterogeneity of presentations. We report a case of late-onset MADD manifesting first as a sensory neuropathy before progressing to myopathic symptoms and acute metabolic decompensation. Early diagnostic workup with acylcarnitine profiling and organic acid analysis was critical in patient outcome; metabolic decompensation and myopathic symptoms were completely reversed with riboflavin supplementation and dietary modification, although sensory neuropathy persisted. Clinical consideration of MADD as part of the differential diagnosis of neuropathy with myopathy is crucial for a timely diagnosis and treatment of MADD.
- 15 March 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (3) , e259192
Sensory neuropathy as a manifestation of multiple acyl-coenzyme A dehydrogenase deficiency
Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is a rare metabolic disorder which typically manifests with muscle weakness. However, despite late-onset MADD being treatable, it is often misdiagnosed, due in part to the heterogeneity of presentations. We report a case of late-onset MADD manifesting first as a sensory neuropathy before progressing to myopathic symptoms and acute metabolic decompensation. Early diagnostic workup with acylcarnitine profiling and organic acid analysis was critical in patient outcome; metabolic decompensation and myopathic symptoms were completely reversed with riboflavin supplementation and dietary modification, although sensory neuropathy persisted. Clinical consideration of MADD as part of the differential diagnosis of neuropathy with myopathy is crucial for a timely diagnosis and treatment of MADD.
- Open Access
- 16 January 2024
- Published by Elsevier in The Lancet Psychiatry
- Vol. 11 (4) , 295-302
A new predictive coding model for a more comprehensive account of delusions
- 16 January 2024
- Published by Elsevier in The Lancet Psychiatry
- Vol. 11 (4) , 295-302
Open AccessA new predictive coding model for a more comprehensive account of delusions